Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 4/20 | 0.58 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.58 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.58 |
| ▸ | REN | P00797 | 11/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.55 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.55 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.52 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29569038 | 0.94 | NTSR2 (0.61) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29568664 | 0.93 | REN (0.62) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29569380 | 0.93 | REN (0.62) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29568867 | 0.93 | REN (0.62) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29568825 | 0.92 | REN (0.61) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29568543 | 0.92 | C5AR1 (0.63) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29568811 | 0.91 | REN (0.60) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL30670298 | 0.91 | AGTR1 (0.62) | NTSR2NTSR1SORT1AGTR1AGTR2 | |
| SCHEMBL29701255 | 0.90 | SLC6A2 (0.63) | NTSR2NTSR1SORT1RENAGTR1 | |
| SCHEMBL29569641 | 0.90 | REN (0.61) | NTSR2NTSR1SORT1RENAGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | NTSR2 772/4885NTSR1 810/4885SORT1 2293/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | NTSR2 772/4885NTSR1 810/4885SORT1 2293/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | NTSR2 772/4885NTSR1 810/4885SORT1 2293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.